Finn Guo: Driving a New Era of Accessible Gene Therapy for Hemophilia in China
Finn Guo, Director of Information Research at Illness Challenge Foundation, shared on LinkedIn:
”From launching the project in March to completing the research report ‘Payment Mechanism and Global Strategies for Innovative Hemophilia Therapies’ in June — officially presented at the International Hemophilia Conference.
We started with patient surveys to truly understand the challenges, drew insights from international best practices, and finally developed practical solution frameworks.
While the scheme is still a long way from real-world implementation, I’m truly excited that the rapid progress in China’s domestic gene therapy for hemophilia — combined with current market pricing — is set to usher China into a new era of accessible gene therapy.
Hope is on the horizon.”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime